| Recommendation |
sources |
| WHO/IARC/RITA |
NACAD |
STP |
| focus of cellular alteration [amphophilic; basophilic, diffusely; basophilic, tigroid; basophilic/eosinophilic mixed; basophilic, NOS; clear cell; eosinophilic] (H) |
focus of cellular alteration [amphophilic; basophilic, diffusely; basophilic, tigroid; basophilic/eosinophilic mixed; clear cell; eosinophilic] (H) |
focus of cellular alteration [amphophilic; basophilic, diffusely; basophilic, tigroid; basophilic/eosinophilic mixed; clear cell; eosinophilic] (H) |
foci of cellular alteration |
| hyperplasia, hepatocellular, regenerative (H) |
hyperplasia, hepatocellular, regenerative (H) |
hyperplasia, hepatocellular, regenerative (H) |
regenerative hyperplasia |
| cholangiofibrosis (H) |
cholangiofibrosis (H) |
cholangiofibrosis (H) |
cholangiofibrosis |
| cholangiofibroma (B) |
|
|
|
| hyperplasia, oval cell (H) |
oval cell proliferation (H) |
hyperplasia, oval cell (H) |
oval cell hyperplasia |
| adenoma, hepatocellular (B) |
adenoma, hepatocellular (B) |
adenoma, hepatocellular (B) |
hepatocellular adenoma |
| carcinoma, hepatocellular [acinar; solid; trabecular] (M) |
carcinoma, hepatocellular [acinar; solid; trabecular] (M) |
carcinoma, hepatocellular [acinar; solid; trabecular] (M) |
hepatocellular carcinoma |
| hyperplasia, bile duct [cystic] (H) |
hyperplasia, bile duct [cystic] (H) |
hyperplasia, bile duct [cystic] (H) |
bile duct hyperplasia |
| cholangioma (B) |
cholangioma [cystic; simple] (B) |
cholangioma (B) |
cholangioma |
| cholangiocarcinoma (M) |
cholangiocarcinoma (M) |
cholangiocarcinoma (M) |
cholangiocarcinoma |
| adenoma, hepatocholangiocellular (B) |
|
adenoma, hepatocholangiocellular (B) |
hepatocholangiocellular adenoma |
| carcinoma, hepatocholangiocellular (M) |
|
carcinoma, hepatocholangiocellular (M) |
hepatocholangiocellular carcinoma |
| |
|
karyomegaly |
|
| |
|
cystic degeneration |
|
| |
|
angiectasis |
|
| |
|
ectopic pancreas |
|